Skip to main content
. 2013 Apr 10;18(4):391–407. doi: 10.1634/theoncologist.2012-0410

Figure 2.

Figure 2.

Cell signaling pathways for pheochromocytoma and paraganglioma susceptibility genes, showing cluster 2-related kinase signaling pathways. Cluster 2 tumors include RET and NF-1 mutations and are characterized by a RAS/RAF/ERK signaling phenotype with increased expression of genes involved in adrenergic metabolism.